Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential, both as monotherapies and in combination with other interventions, across multiple disease interventions
The success of CTLA4, PD-1, and PD-L1 inhibitors paved the way for researchers to explore the vast therapeutic potential of immune checkpoint modulation, enabling the discovery of product candidates against clinical conditions beyond oncology
Increasing demand for energy efficient lighting solutions and growing number of smart city projects across the globe are amongst the key drivers behind the evolution of the smart lighting market
Roots Analysis has announced the addition of “Smart ... Read more
Increasing awareness related to the importance of reducing carbon footprint across the globe, has compelled individuals to adopt cleaner mobility alternatives, such as electric vehicles
The rapidly growing demand for oligonucleotides, coupled to complex manufacturing procedures and high capital investments required for setting up manufacturing facilities, has generated a range of new opportunities for custom manufacturers
Compared to batch production methods, continuous manufacturing is not only more time-efficient, but is also associated with reduced energy needs, lower footprint and includes provisions to trace process-related errors and inefficiencies
Traditional drug discovery is associated with exorbitant investments, prolonged lead evolution timelines and high attrition rates; the fragment-based approach is a versatile technique, enabling researchers to mitigate a number of existing challenges
Having demonstrated the ability to offer improved treatment related outcomes and also enhance the quality of lives of patients suffering from a diverse range of clinical conditions, the demand for cell therapies is anticipated to increase in the near future
Connect